about
The Sinbad retrotransposon from the genome of the human blood fluke, Schistosoma mansoni, and the distribution of related Pao-like elementsIdentification and characterization of a novel retroviral-like aspartic protease specifically expressed in human epidermisMolecular and biotechnological aspects of microbial proteasesRole of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1Activity of purified biosynthetic proteinase of human immunodeficiency virus on natural substrates and synthetic peptidesViral cysteine proteases are homologous to the trypsin-like family of serine proteases: structural and functional implicationsActive human immunodeficiency virus protease is required for viral infectivityHuman immunodeficiency virus has an aspartic-type protease that can be inhibited by pepstatin AKnowledge-based model building of proteins: concepts and examplesConsensus structural models for the amino terminal domain of the retrovirus restriction gene Fv1 and the murine leukaemia virus capsid proteinsCharacterization of the protease domain of Rice tungro bacilliform virus responsible for the processing of the capsid protein from the polyproteinFoamy virus assembly with emphasis on pol encapsidationSolution structure of the mature HIV-1 protease monomer: insight into the tertiary fold and stability of a precursorEffect of the Active Site D25N Mutation on the Structure, Stability, and Ligand Binding of the Mature HIV-1 ProteaseHighly conserved glycine 86 and arginine 87 residues contribute differently to the structure and activity of the mature HIV-1 proteaseX-ray crystallographic structure of a complex between a synthetic protease of human immunodeficiency virus 1 and a substrate-based hydroxyethylamine inhibitorCrystal structure of a putative aspartic proteinase domain of theMycobacterium tuberculosiscell surface antigen PE_PGRS16Effects of Hinge Region Natural Polymorphisms on Human Immunodeficiency Virus-1 Protease Structure, Dynamics and Drug-Pressure EvolutionKnowledge-Based Protein ModelingIn vitro inhibition of HIV-1 proteinase by ceruleninAntiviral and pharmacokinetic properties of C2 symmetric inhibitors of the human immunodeficiency virus type 1 proteaseAn inhibitor of the protease blocks maturation of human and simian immunodeficiency viruses and spread of infectionInhibition of human immunodeficiency virus 1 protease in vitro: rational design of substrate analogue inhibitorsChemical synthesis and enzymatic activity of a 99-residue peptide with a sequence proposed for the human immunodeficiency virus proteaseSelection and analysis of human immunodeficiency virus type 1 variants with increased resistance to ABT-538, a novel protease inhibitorPotency and selectivity of inhibition of human immunodeficiency virus protease by a small nonpeptide cyclic urea, DMP 323L-735,524: an orally bioavailable human immunodeficiency virus type 1 protease inhibitorAntiretroviral activities of protease inhibitors against murine leukemia virus and simian immunodeficiency virus in tissue cultureEvidence that the Bacillus subtilis SpoIIGA protein is a novel type of signal-transducing aspartic proteaseNetwork dynamics of eukaryotic LTR retroelements beyond phylogenetic treesStructural design and molecular evolution of a cytokine receptor superfamilyHIV protease inhibitors inhibit the development of preerythrocytic-stage plasmodium parasites.Requirements for incorporation of Pr160gag-pol from human immunodeficiency virus type 1 into virus-like particles.Design and characterization of a membrane permeable N-methyl amino acid-containing peptide that inhibits Abeta1-40 fibrillogenesis.Toxoneuron nigriceps polydnavirus encodes a putative aspartyl protease highly expressed in parasitized host larvae.Retrotransposon-like nature of Tp1 elements: implications for the organisation of highly repetitive, hypermethylated DNA in the genome of Physarum polycephalum.Understanding HIV-1 protease autoprocessing for novel therapeutic development.Cauliflower mosaic virus produces an aspartic proteinase to cleave its polyproteinsSynthetic peptides as substrates and inhibitors of a retroviral protease.Isolation of mutants of human immunodeficiency virus protease based on the toxicity of the enzyme in Escherichia coli.
P2860
Q21093609-9CF42546-27CB-40C6-AF48-BEF24D0A9F6BQ24314564-260742F3-322C-411C-B949-FFC59F46AA64Q24548591-D681105A-2C8B-49D2-BB1C-34DD94F88D57Q24609814-7A25DFF9-8E7C-46D2-8E5B-5C6ECC87AE43Q24627225-F14DFAB0-2937-48A8-844F-B9B270D4F3D1Q24647040-D6952A37-6B33-487B-A70E-5902552B2BC7Q24647696-27C69498-F585-4671-AFDE-BE264F86F20CQ24649411-8EF7EE52-6E10-43E1-8BFA-A60A35CBDCAEQ24676038-570A5108-F7C7-40D1-ABD4-A009D8B1216DQ24794561-63890D81-0EDA-4301-AFA1-A789E1E4DFF5Q24795879-EF193F1E-1230-49E8-A927-2F7AF4616F6CQ26860084-30701A09-68CA-4321-91FF-DF8055D5B69BQ27641889-CF4BE275-3D85-464D-871F-C967C113ED07Q27649876-6C97F24E-CDB5-4286-8AC8-C3ED9DA3BE8EQ27658105-715F8E27-A13E-43EA-9702-2420D4D67A70Q27678325-33DAFFD8-CF9A-4CF5-BD1A-F66540AB4674Q27679429-724602ED-E978-45BD-82FE-4EDB265993B0Q27727967-46DE3F0F-3B62-4F36-A4C2-1A48760323FFQ28315523-2EC0EF92-3299-42A8-9A59-FABB801C4E60Q28323236-2746E62F-4594-41DE-B41D-01D7446A874DQ28325705-F8BB4422-9837-4D96-BBE2-9EED654DDF39Q28331494-05E33732-5EBD-46F0-B93B-285FF4C9A7F1Q28355570-69CE8150-C145-4FC8-BBDB-5A577F1506BFQ28360614-3D56E9F7-F96B-402D-90EE-B3BE09F436F0Q28368263-1E0FDDDD-2E38-40D0-8353-E1B36CD5F894Q28369098-1A64CA58-484A-4627-A8D8-756142994C9CQ28369664-8B95DE42-644C-49E0-ADAF-959E0CDD5B6FQ28378612-3B1D0538-5BC4-48E6-9690-C9C7E5AE59B9Q28489003-AA9294F5-3A17-4D8E-AA96-4E1E3742792BQ28750250-37E4B816-1C60-4F50-92F1-31D01CE09653Q29618154-7A9A2240-7F15-4190-8EBC-4B7E87D245DDQ30373475-9244EA2D-86EC-4BA1-A565-F6F6705172E7Q30452154-3CBAB94D-957C-4747-A3F7-E09C1D208416Q30700035-DA3E9760-C7D5-4502-B888-A242D9638B42Q33185794-31BEFE70-16E6-4F90-B89C-8C0765B449B4Q33262172-330183D4-577F-4C30-8C18-25063BEDBC5BQ33356201-54206FF8-2E4A-4A80-A853-366F889B9B4CQ33579315-7AECFADA-C08A-465D-8979-A0F4EB39A462Q33580337-9671FD24-0BAA-411E-ACC5-AEA08614B43DQ33703756-23A11140-D1F8-4E94-8D6E-57793F271061
P2860
description
1987 nî lūn-bûn
@nan
1987 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
A structural model for the retroviral proteases.
@ast
A structural model for the retroviral proteases.
@en
A structural model for the retroviral proteases.
@nl
type
label
A structural model for the retroviral proteases.
@ast
A structural model for the retroviral proteases.
@en
A structural model for the retroviral proteases.
@nl
prefLabel
A structural model for the retroviral proteases.
@ast
A structural model for the retroviral proteases.
@en
A structural model for the retroviral proteases.
@nl
P356
P1433
P1476
A structural model for the retroviral proteases
@en
P2093
P2888
P304
P356
10.1038/329351A0
P407
P577
1987-09-01T00:00:00Z
P6179
1018103213